Canopy Growth (CGC) stock forecast for 2023. Forecast tables and graphs.

Canopy Growth (CGC) stock forecast for 2023

The forecast has been updated: June 20, 2021 11:31


Canopy Growth stock price online today

Analyst Target Price

None

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

None

Last Split Date

-

Should you buy or sell Canopy Growth stock stock today? What is the projected target price level for 2023? How much will it cost in 2023? Canopy Growth stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2023.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $None target price for Canopy Growth stock stock.

Today 200 Day Moving Average is the resistance level (30.1604 $).

50 Day Moving Average is the resistance level (24.4286 $).




CGC Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 26.10 25.04 28.17 11.12 %
Feb 25.67 24.90 27.40 9.13 %
Mar 25.28 23.01 26.38 12.79 %
Apr 26.57 25.77 28.64 10.02 %
May 25.02 22.69 26.63 14.80 %
Jun 24.83 23.79 26.51 10.26 %
Jul 28.40 25.81 29.98 13.93 %
Aug 26.66 24.70 28.02 11.85 %
Sep 28.90 26.64 31.50 15.41 %
Oct 28.55 25.34 31.08 18.47 %
Nov 27.14 26.00 28.68 9.37 %
Dec 25.51 24.44 27.42 10.88 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Canopy Growth stock.


Canopy Growth overview

Canopy Growth Address

1 HERSHEY DRIVE, SMITH FALLS, ON, CA

Market Capitalization

8 850 470 912 $

EBITDA

-

PE Ratio

None

PEG Ratio

None

Dividend Per Share

None

Dividend Yield

0

EPS

-1.794

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0.376

Trailing PE

0

Forward PE

0

EV To Revenue

16.1229

EV To EBITDA

0

52 Week High

50.92

52 Week Low

13.83

50 Day Moving Average

24.4286

200 Day Moving Average

30.1604

Shares Outstanding

382977984

Shares Float

274637488

Shares Short Prior Month

17024362

Short Ratio

4.42

Percent Insiders

37.969

Percent Institutions

15.392

Canopy Growth stock forecast for this year


Canopy Growth stock forecast for Jan 2023.
Estimated Average Forecasted Canopy Growth Price: 26.10. Positive monthly dynamics of the instrument is expected with 11.116% volatility is expected.

Pessimistic forecast: 25.04

Optimistic: 28.17


Canopy Growth stock forecast for Feb 2023.
Estimated Average Forecasted Canopy Growth Price: 25.67. Negative monthly dynamics of the instrument is expected with 9.133% volatility is expected.

Pessimistic forecast: 24.90

Optimistic: 27.40


Canopy Growth stock forecast for Mar 2023.
Estimated Average Forecasted Canopy Growth Price: 25.28. Negative monthly dynamics of the instrument is expected with 12.793% volatility is expected.

Pessimistic forecast: 23.01

Optimistic: 26.38


Canopy Growth stock forecast for Apr 2023.
Estimated Average Forecasted Canopy Growth Price: 26.57. Positive monthly dynamics of the instrument is expected with 10.018% volatility is expected.

Pessimistic forecast: 25.77

Optimistic: 28.64


Canopy Growth stock forecast for May 2023.
Estimated Average Forecasted Canopy Growth Price: 25.02. Negative monthly dynamics of the instrument is expected with 14.796% volatility is expected.

Pessimistic forecast: 22.69

Optimistic: 26.63


Canopy Growth stock forecast for Jun 2023.
Estimated Average Forecasted Canopy Growth Price: 24.83. Negative monthly dynamics of the instrument is expected with 10.258% volatility is expected.

Pessimistic forecast: 23.79

Optimistic: 26.51


Canopy Growth stock forecast for Jul 2023.
Estimated Average Forecasted Canopy Growth Price: 28.40. Positive monthly dynamics of the instrument is expected with 13.927% volatility is expected.

Pessimistic forecast: 25.81

Optimistic: 29.98


Canopy Growth stock forecast for Aug 2023.
Estimated Average Forecasted Canopy Growth Price: 26.66. Negative monthly dynamics of the instrument is expected with 11.846% volatility is expected.

Pessimistic forecast: 24.70

Optimistic: 28.02


Canopy Growth stock forecast for Sep 2023.
Estimated Average Forecasted Canopy Growth Price: 28.90. Positive monthly dynamics of the instrument is expected with 15.413% volatility is expected.

Pessimistic forecast: 26.64

Optimistic: 31.50


Canopy Growth stock forecast for Oct 2023.
Estimated Average Forecasted Canopy Growth Price: 28.55. Negative monthly dynamics of the instrument is expected with 18.466% volatility is expected.

Pessimistic forecast: 25.34

Optimistic: 31.08


Canopy Growth stock forecast for Nov 2023.
Estimated Average Forecasted Canopy Growth Price: 27.14. Negative monthly dynamics of the instrument is expected with 9.366% volatility is expected.

Pessimistic forecast: 26.00

Optimistic: 28.68


Canopy Growth stock forecast for Dec 2023.
Estimated Average Forecasted Canopy Growth Price: 25.51. Negative monthly dynamics of the instrument is expected with 10.884% volatility is expected.

Pessimistic forecast: 24.44

Optimistic: 27.42



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 111.7 (24.06.2021) 0.78 %
AbbVie Inc.
ABBV 114.74 (24.06.2021) 0.65 %
Aeterna Zentaris Inc.
AEZS 0.9101 (23.06.2021) 4.01 %
Allakos Inc.
ALLK 94.26 (24.06.2021) 3.31 %
Allogene Therapeutics, Inc.
ALLO 24.16 (24.06.2021) 2.85 %
Amgen Inc.
AMGN 240.95 (24.06.2021) 0.94 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 16.58 (24.06.2021) 6.97 %
Aurora Cannabis Inc.
ACB 9.35 (24.06.2021) 3.66 %
Becton Dickinson and Company
BDX 239.82 (24.06.2021) -0.17 %
Biogen Inc.
BIIB 349.16 (24.06.2021) -6.11 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 97.27 (24.06.2021) -0.46 %
BioNTech SE
BNTX 227.79 (24.06.2021) -0.75 %
bluebird bio, Inc.
BLUE 32.33 (24.06.2021) -0.12 %
Boston Scientific Corp.
BSX 43.71 (24.06.2021) -0.18 %
Bristol-Myers Squibb Company
BMY 65.85 (24.06.2021) 0.90 %
Canopy Growth Corp.
CGC 24.72 (24.06.2021) 4.88 %
Castle Biosciences, Inc.
CSTL 75.09 (24.06.2021) 0.55 %
Eli Lilly and Company
LLY 232.97 (24.06.2021) 7.31 %
Emergent BioSolutions Inc.
EBS 61.85 (24.06.2021) 3.00 %
Exelixis, Inc.
EXEL 22.86 (24.06.2021) 2.88 %
G1 Therapeutics, Inc.
GTHX 23.27 (24.06.2021) 6.55 %
Gilead Sciences, Inc.
GILD 67.18 (24.06.2021) 0.80 %
GlaxoSmithKline plc
GSK 39.7 (24.06.2021) -0.38 %
GoodRx Holdings, Inc.
GDRX 38.94 (24.06.2021) 1.83 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 86.13 (24.06.2021) 1.17 %
Inovio Pharmaceuticals, Inc.
INO 8.89 (24.06.2021) 2.30 %
Johnson & Johnson
JNJ 163.37 (24.06.2021) 0.46 %
Medtronic plc.
MDT 125.09 (24.06.2021) -0.32 %
Merck & Co., Inc.
MRK 76.36 (24.06.2021) 1.03 %
Moderna, Inc.
MRNA 220.14 (24.06.2021) 3.82 %
Novartis AG
NVS 92.46 (24.06.2021) 0.08 %
Novavax, Inc.
NVAX 192.48 (24.06.2021) 0.12 %
ObsEva SA
OBSV 3.01 (23.06.2021) 2.38 %
OrganiGram Holdings Inc.
OGI 3.07 (24.06.2021) 3.37 %
Pfizer Inc.
PFE 39.19 (24.06.2021) 0.36 %
Regeneron Pharmaceuticals, Inc.
REGN 544.45 (24.06.2021) 2.77 %
Sanofi
SNY 52.32 (24.06.2021) 0.46 %
Schrodinger, Inc.
SDGR 78.46 (24.06.2021) 2.07 %
Senseonics Holdings, Inc.
SENS 3.61 (24.06.2021) 0.56 %
Sorrento Therapeutics, Inc.
SRNE 9.04 (23.06.2021) 1.23 %
Stryker Corp.
SYK 261.39 (24.06.2021) -0.48 %
Sundial Growers Inc.
SNDL 1 (24.06.2021) 0.00 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 10.42 (24.06.2021) 2.16 %
Thermo Fisher Scientific Inc.
TMO 495.36 (24.06.2021) 0.27 %
Tilray, Inc.
TLRY 18.26 (24.06.2021) 3.69 %
UnitedHealth Group, Inc.
UNH 398.87 (24.06.2021) 0.84 %
Veeva Systems Inc.
VEEV 312 (24.06.2021) 0.28 %
Zomedica Corp.
ZOM 0.8401 (24.06.2021) -0.88 %
Zynerba Pharmaceuticals, Inc.
ZYNE 5.77 (24.06.2021) 3.59 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.